Insider trades

Ho Carole, Director of Royalty Pharma RPRX, has filed 0 purchases and 24 sales on the open market. The latest trade was on 06/05.

Ho Carole

Director
First filing
23/01/05
Trades
45 trades
Buys / sales
0 / 24
12-month net buying
No record
Last trade
06/05

Trading activity

Transactions

Trade type
DNLI
Open-market sale10b5-1 plan25/08/12–25/08/1325/08/143,743 sh2 trades$13.81avg.$51,684.3−1.7%
DNLI
Open-market sale25/01/06–25/01/0725/01/0815,162 sh2 trades$20.33avg.$308,290.77−7.9%
DNLI
Open-market sale10b5-1 plan24/08/20–24/08/2124/08/2222,458 sh3 trades$24.49avg.$549,927.77−15.9%
Open-market sale24/08/1324/08/152,337 sh$22.89$53,493.93−1.6%
DNLI
Open-market sale10b5-1 plan24/02/13–24/02/1424/02/154,189 sh2 trades$17.46avg.$73,130.31−2.8%
Open-market sale10b5-1 plan24/01/1024/01/124,668 sh$19.02$88,785.36−3.1%
Open-market sale24/01/0524/01/099,972 sh$19.43$193,755.96−4.8%
Open-market sale23/08/2323/08/252,522 sh$23.22$58,560.84−1.4%
Open-market sale23/08/2123/08/232,478 sh$22.60$56,002.8−1.3%
Open-market sale10b5-1 plan23/08/1423/08/162,768 sh$23.79$65,850.72−1.5%
Open-market sale23/08/1023/08/142,857 sh$24.15$68,996.55−1.5%
Open-market sale23/02/1523/02/171,476 sh$29.40$43,394.4−0.8%
DNLI
Open-market sale23/02/10–23/02/1323/02/143,366 sh2 trades$30.03avg.$101,071.2−1.8%
Open-market sale23/02/0823/02/101,521 sh$30.88$46,968.48−0.8%
Open-market sale23/01/0923/01/101,459 sh$28.48$41,552.32−0.8%
DNLI
Open-market sale23/01/05–23/01/0623/01/094,087 sh2 trades$28.52avg.$116,568.01−2.2%
Open-market sale23/01/0423/01/052,913 sh$28.69$83,573.97−1.6%